AT263371T

Therapeutic agent with quantitative consumption marker and method of monitoring therapeutic agent consumption

Abstract

(57) Each thing which is examined by the quantitive compliance marker and the related method for monitoring the patient according to the prescription of drug combined with the summary compliance marker, which is and whose necessity quantitive-related specific carries out new, and is lost to a medicine was discovered. The method for monitoring whether such a compliance marker and a patient follow directions, Use with the given dose which can measure the benzodiazepines or the non-metabolic substance of an inactive substance, i. E. , weak acid, in combination with a basic medicine pharmacologically, compliance marker concentration is made to correlate with basic medicine concentration, and the quantity of the actual medicine taken in is determined.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

44 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
71501696United States of AmericaA
9716416United States of AmericaW

Members44

Family members, oldest first
DocumentOfficeKind
CA2175584A1CanadaA1
WO9512812A1World Intellectual Property Organization (WIPO)A1
AU8087394AAustraliaA
US5547878AUnited States of AmericaA
EP0748444A1European Patent Office (EPO)A1
US5652146AUnited States of AmericaA
EP0748444A4European Patent Office (EPO)A4
JPH09508967AJapanA
CA2265795A1CanadaA1
CA2526433A1CanadaA1
WO9812557A1World Intellectual Property Organization (WIPO)A1
AU4482697AAustraliaA
US5776783AUnited States of AmericaA
AU698403B2AustraliaB2
CA2295905A1CanadaA1
WO9902983A1World Intellectual Property Organization (WIPO)A1
AU8280898AAustraliaA
US5908788AUnited States of AmericaA
US5955370AUnited States of AmericaA
EP0944828A1European Patent Office (EPO)A1
EP0944828A4European Patent Office (EPO)A4
EP0995114A1European Patent Office (EPO)A1
US6124136AUnited States of AmericaA
JP2001507118AJapanA
JP2001509601AJapanA
AU736645B2AustraliaB2
AU4806301AAustraliaA
AU742863B2AustraliaB2
AU758193B2AustraliaB2
EP0748444B1European Patent Office (EPO)B1
AT245814TAustriaT
ATE245814T1AustriaT1
DE69432976D1GermanyD1
EP0944828B1European Patent Office (EPO)B1
AT263371TThis recordAustriaT
ATE263371T1AustriaT1
DE69728418D1GermanyD1
EP0995114A4European Patent Office (EPO)A4
CA2175584CCanadaC
CA2295905CCanadaC
CA2265795CCanadaC
JP4179748B2JapanB2
JP4389005B2JapanB2
CA2526433CCanadaC